Having left HeLEX at the University of Oxford in 2020, Dr Harriet Teare is now Research Leader at RAND Europe, Cambridge.
Dr Harriet Teare was a Researcher in Healthcare and Policy, contributing to a programme of work addressing Global Access to Medicines (in collaboration with members of the Structural Genomics Consortium, Oxford). She had previously provided research governance and ethical support to the DIRECT project – an IMI-JU funded collaboration exploring stratification in Type 2 diabetes, the Rudy Study – a research network for rare diseases of the blood, bone and joints, and led a work package focusing on consent in the Genetics Clinic of the Future – a Horizon 2020 project mapping the complex challenges that will need to be tackled to introduce genome sequencing more widely into the clinic. Harriet obtained a DPhil in Organic and Medicinal Chemistry from Merton College, Oxford, and previously worked as a Senior Policy Advisor at Cancer Research UK, focusing on policy issues relating to science and research, and public health.
Harriet remains an Academic Affiliate of HeLEX.